Skip to content

Study on the effect of music therapy on the improvement of psychological and physiological status and quality of life of patients with digestive tract malignant tumor chemotherapy

Study on the effect of music therapy on the improvement of psychological and physiological status and quality of life of patients with digestive tract malignant tumor chemotherapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098110
Enrollment
Unknown
Registered
2025-03-03
Start date
2024-07-17
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive tract tumor

Interventions

Experimental group:Music Intervention on the Basis of Conventional Chemotherapy Regimen 1.Experimental group: In collaboration with psychotherapists and nurses, a music playlist is prepared for each p
Control group:No music intervention, conventional chemotherapy treatment

Sponsors

Sichuan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with malignant tumors of digestive tract (gastric cancer, colorectal cancer, pancreatic cancer) confirmed by clinicopathology; 2. The patient has normal cognitive function, reading and writing ability; 3. The patient is informed and agrees to participate in clinical research, and has certain language expression ability; 4. Patient compliance is good, age 18-65 years old, male and female; 5. Patients are expected to survive at least six months or more before chemotherapy; 6. The chemotherapy regimen of the patient was fluorouracil chemotherapy drugs, and the duration of each chemotherapy cycle was the same and more than 4 cycles of chemotherapy could be completed; 7. The patient had normal hearing and had not undergone music therapy within one year.

Exclusion criteria

Exclusion criteria: 1.Patients with malignant tumors in locations other than the digestive tract (stomach cancer, colorectal cancer, pancreatic cancer). 2.Patients with impaired consciousness, cognitive disorders, or hearing impairments. 3.Patients with severe damage to vital organs such as the liver and lungs. 4.Patients with malignant digestive tract tumors undergoing immunotherapy.

Design outcomes

Primary

MeasureTime frame
Self-Rating Anxiety Scale (SAS) score;

Secondary

MeasureTime frame
Self-Rating Depression Scale(SDS) score;EOTRC QLQ-C30 v3.0;Vital sign;

Countries

China

Contacts

Public ContactHaiyu Zhang

Sichuan Cancer Hospital

zhanghaiyu@scszlyy.org.cn+86 135 4025 0461

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026